MEK Inhibitors in Neurofibromatosis Type 1: Nursing Contributions to NF1-PN Management

Name: MM-154 Resource Page
Uploaded: 2025-09-22T14:09:52+0000
Description: MEK Inhibitors in Neurofibromatosis Type 1: Nursing Contributions to NF1-PN Management View the Presentation Download the Booklet Apply for Credit Faculty Amy Armstrong, MD AeRang Kim, MD, PhD Sanita Burgic, MSN, APRN, AGNP-C Renie Moss Patient Advocate and Caregiver This program is supported through independent educational grants from Alexion Pharmaceuticals and SpringWorks Therapeutics, Inc.